Isolation of inhibitor of IRES-mediated translation

Details for Australian Patent Application No. 2006228994 (hide)

Owner Telethon Institute for Child Health Research

Inventors Fear, Mark

Agent FB Rice

Pub. Number AU-A-2006228994

PCT Pub. Number WO2006/102720

Priority 2005901574 31.03.05 AU

Filing date 31 March 2006

Wipo publication date 5 October 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102720 Priority application(s): WO2006/102720

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228996-Process for the production of gammaglutamylcysteine

2006228992-A healthcare administration system